The Clinical Benefits of Antiresorptive Agents in Patients with Primary Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review with Pairwise and Network Meta-analysis.
J Clin Endocrinol Metab
; 108(11): e1433-e1447, 2023 10 18.
Article
in En
| MEDLINE
| ID: mdl-37170778
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Bone Density Conservation Agents
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Female
/
Humans
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2023
Document type:
Article
Country of publication: